1. Outcomes of Lateral Meniscal Oblique Radial Tear Repair Compared With Intact Meniscus After ACL Reconstruction: A Cohort Study.
- Author
-
Therrien E, Langhans MT, Lamba A, Daniel AV, Stuart MJ, Levy BA, Smith PA, and Krych AJ
- Abstract
Background: Recently, the posterior horn lateral meniscal oblique radial tear (LMORT) was identified in 12% of acute anterior cruciate ligament (ACL) injuries. However, patient-reported outcomes for repair of this relatively common tear have not been reported., Purpose: To determine the minimum 2-year functional outcomes after LMORT repair at the time of ACL reconstruction (ACLR) compared to a matched cohort of patients who underwent isolated ACLR (iACLR)., Study Design: Cohort study; Level of evidence, 3., Methods: Included were 100 patients (mean age at surgery, 21 years; range, 13-45 years) who underwent primary ACLR between 2010 and 2018. The mean follow-up period was 4.1 ± 2.0 years (range, 2.0-9.2 years). A total of 50 patients with surgically repaired LMORT type 3 or type 4 lesions, defined as partial or complete tears >10 mm from the root (LMORT group) were matched 1:1 based on age, date of surgery, and graft choice with 50 patients who underwent iACLR (iACLR group). The postoperative outcomes were compared between groups using the International Knee Documentation Committee subjective score (sIKDC) and the Tegner activity scale. An updated medical history was obtained via the electronic medical record to determine any subsequent complications and reoperations., Results: There was 1 ACL graft failure in each group as well as 5 (10%) reoperations per group. None of the patients in the LMORT group necessitated a lateral meniscal revision repair or partial meniscectomy. The LMORT and iACLR groups reported comparable sIKDC scores (92.5 ± 6.8 vs 91.9 ± 8.2, respectively; P = .712) as well as Tegner scores (6.7 ± 1.8 vs 6.6 ± 1.8, respectively; P = .910) at final follow-up. No failures of the LMORT repairs were reported., Conclusion: The study findings demonstrated that reoperations, graft failure rates, patient-reported outcomes, and patient activity levels at ≥2 years after type 3 and 4 LMORT repairs at the time of ACLR compared favorably with those of a matched cohort of patients who underwent iACLR with intact meniscus., Competing Interests: The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the US National Institutes of Health. One or more of the authors has declared the following potential conflict of interest or source of funding: Research support was received from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program (T32AR56950) and from the Foderaro-Quattrone Musculoskeletal/Orthopaedic Surgery Research Innovation Fund. E.T. has received a grant from Arthrex, education payments from Arthrex, and hospitality payments from Stryker. M.J.S. has received research support from Stryker, education payments from Arthrex, consulting fees from Arthrex, nonconsulting fees from Arthrex, and royalties from Arthrex. B.A.L. has received consulting fees from Arthrex and Smith & Nephew; nonconsulting fees from Arthrex, Smith & Nephew, and Linvatec; royalties from Arthrex; and stock from COVR Medical. P.A.S. has received research support from Arthrex; education payments from United Orthopedics and Elite Orthopedics; consulting fees from Arthrex; nonconsulting fees from Arthrex, Kairos Surgical, United Orthopedics, Medical Device Business Services, Elite Orthopedics, and Alpha Orthopedic systems; royalties from Arthrex; and stock options from Spinal Simplicity. A.J.K. has received research support from Aesculap, B. Braun, Ceterix, Arthritis Foundation, Histogenics, and Arthrex; a grant from DJO; consulting fees from Arthrex, Vericel, JRF Ortho, and Responsive Arthroscopy; nonconsulting fees from Arthrex; royalties from Arthrex and Responsive Arthroscopy; honoraria from JRF Ortho, MTF Biologics, and Responsive Arthroscopy; and hospitality payments from Gemini Mountain Medical and Smith & Nephew. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. Ethical approval for this study was obtained from Mayo Clinic (reference No. PR15-000601-09)., (© The Author(s) 2023.)
- Published
- 2023
- Full Text
- View/download PDF